AUREALIS PHARMA

Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.